STAT proteins and their mechanisms of signaling were originally de®ned largely in the context of normal interferon signaling, where they have been shown to have speci®c roles in mediating host defenses. While much of the early investigations of STATs focused on interferon signaling, the fundamental roles of STATs in highly diverse biological processes are being increasingly recognized. For example, it is now known that many cytokines, hormones and growth factors utilize STAT signaling pathways to control a remarkable variety of biological responses, including development, dierentiation, cell proliferation and survival. Given the critical roles of STAT proteins in these fundamental cellular processes, which are often perturbed in cancer, it is not surprising that inappropriate activation of STAT signaling pathways is also increasingly associated with oncogenesis. Indeed, there is mounting evidence for the participation of constitutively-activated STAT signaling in cell transformation by numerous oncogenes and in malignant progression of many human cancers. Furthermore, the oncogenic potential of certain STAT family members, particularly Stat3 and Stat5, can be directly activated by point mutations. For these reasons, a comprehensive collection of reviews on the many facets of STAT signaling pathways is both timely and appropriate for this series. This exciting collection not only informs on the cellular mechanisms and biological importance of STAT signaling pathways, but also raises new questions that invite further experimentation.
As will become evident from the superb reviews in this issue, there is much more complexity to STAT signaling pathways than was originally anticipated, adding greatly to the interest in these proteins. For example, a recurring theme is that the regulation and functions of STAT proteins are highly dependent on the cell type and activating stimulus. To a large extent, this speci®city in STAT signaling pathways is likely to result from dierences in cellular context, such as other signaling pathways and transcription factors that interact with the STAT proteins. Thus, the same STAT family member can mediate con¯icting responses in terms of cell proliferation, dierentiation or apoptosis in dierent cellular contexts. These dierences in biological responses are often mirrored in contrasting patterns of gene regulation induced by the same STAT protein in a cell type-dependent manner. Another example of the complexity surrounding STATs is the growing realization that multiple tyrosine kinase (TK) signaling pathways, in addition to the Janus kinase (JAK) family of tyrosine kinases, are able to induce STAT signaling. Hence, as our understanding of the tyrosine kinase signaling pathways that activate STATs becomes more complete, it is perhaps most appropriate to designate generic signaling involving STAT proteins as`TK-STAT' pathways.
Despite their complexity, there is also a certain elegant simplicity to the structure and signaling mechanisms of STAT proteins. To best appreciate these qualities of STATs, we begin this series with a historical perspective and overview of STAT signaling pathways by Bromberg and Darnell. STATs are unique among transcription factors in possessing an SH2 domain that regulates their dimerization and activation via tyrosine phosphorylation. Members of this relatively small family of proteins serve as both transducers of cytoplasmic signals and nuclear transcription factors, thereby directly converting a stimulus at the cell surface to an alteration in the genetic program. As mentioned above, STAT signaling is often subverted in oncogenesis, and the review by Bowman et al. provides an overview of the biochemical and biological mechanisms of STAT signaling in malignant transformation. More speci®c examples of STAT signaling pathways in oncogenesis are presented in several other reviews, including those by Song and Grandis, Lin et al., Levy and Gilliland, Coer et al. and Danial and Rothman. These reviews discuss both the evidence for and against the roles of individual STAT family members in oncogenesis, and evaluate the potential of STAT signaling pathways as novel molecular targets for cancer therapeutics.
One of the interesting surprises has been the contribution of cellular Src kinase, which in its oncogenic form was the ®rst oncoprotein found to activate STATs, to normal cytokine signaling, as discussed by Reddy et al. The central importance of STAT proteins in normal cytokine signaling pathways is the topic of a review by Hirano et al. on IL-6, a cytokine that has historically led the way together with interferons on studies of STAT signaling. STAT signaling by the interferon receptors and related cytokine class II receptors is discussed further in the review by Kotenko and Pestka. The key roles of STATs, particularly Stat5A and Stat5B, in IL-2 signaling are reviewed by Lin and Leonard. STATs STATs have been shown to have important functions during normal development, consistent with their conservation through evolution. Interestingly, homologues of STAT proteins have been identi®ed in the nematode C. elegans, the slime mold Dictyostelium, and the fruit¯y Drosophila. The presence of STATs in organisms that lend themselves to genetic analysis has led to de®nition of novel roles for STAT signaling pathways in development, an excellent example being sex determination in Drosophila as described by Zeidler et al. These genetic systems should also prove valuable for identi®cation of other proteins involved in STAT signaling, such as modulators of STAT activation. In addition to development, another critical role for STATs is in dierentiation, including hematopoiesis, as reviewed by Akira and Smithgall et al.
We conclude this series with a discussion of the complexity surrounding STAT signaling. This is exempli®ed by the complex roles of Stat1 in positive, negative and constitutive regulation of gene expression, discussed in the review by Ramana et al. As elaborated by several reviews in this issue, including the review by Decker and Kovarick, STAT proteins cross-talk with many other central signaling pathways, such as those involving the mitogen-activated protein kinase (MAPK) family of proteins. An interesting line up of other proteins is known to interact with and modulate STAT signaling pathways, including histone acetyltransferases and the PIAS family of proteins, which are described in more detail in the review by Shuai. These STAT interacting proteins likely play key roles at various dierent steps in the pleiotropic and cell context-dependent responses to STAT signaling pathways. Finally, as discussed by Lamb et al., STAT signaling pathways and their regulators/eectors oer bountiful opportunities for development of novel therapeutics for a wide variety of human diseases.
With the explosion of information on STAT proteins in recent years, this is an opportune time to pause and take stock of current understanding about STAT signaling. Within these pages, readers will ®nd not only consensus and paradigm, but also diering perspectives on the regulation and functions of STAT proteins. Importantly, all of the reviews in this issue point out signi®cant areas where there is lack of sucient knowledge and understanding, raising new questions for further study. These outstanding questions often pertain to the increasingly complex biological functions of STAT proteins, the many diverse mechanisms of STAT regulation, and the expanding number of target genes that mediate the biological responses elicited by STAT signaling pathways. In addressing these questions, it is imperative to take not just one but many complementary approaches. The reviews in this issue illustrate the power of multiple approaches to de®ne STAT function in a variety of systems, ranging from fruit¯ies to mouse models to human tumor cells. If this comprehensive collection of reviews on STATs stimulates fresh new thinking and experimentation on STAT signaling pathways, it will have accomplished its goal.
